secwatch.observer — SEC 8-K summary
======================================

Issuer:     Connect Biopharma Holdings Ltd (CNTB)
CIK:        0001835268
Form:       8-K
Filed at:   2025-07-17T23:59:59+00:00
Accession:  0001835268-25-000039
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Connect Biopharma regains Nasdaq minimum bid price compliance; delisting risk removed
--------------------------------------------------------------------------------

- Received Nasdaq letter on July 17, 2025 confirming compliance with Minimum Bid Price Requirement.
- Regained compliance after ADSs closed at or above $1.00 for 10 consecutive business days through July 15, 2025.
- Non-compliance was first notified on March 24, 2025; cure period ran to September 22, 2025.
- Matter is now closed; no further action required to maintain listing.
- Removal of delisting risk supports continued trading on Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835268/000183526825000039/0001835268-25-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835268/000183526825000039/cntb-20250716.htm
  HTML page:      https://secwatch.observer/filing/0001835268-25-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer